Long-term outcomes of newly diagnosed CRLF2 rearranged B-cell ALL.

Authors

Jayastu Senapati

Jayastu Senapati

Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX

Jayastu Senapati , Elias Jabbour , Nicholas James Short , Farhad Ravandi , Partow Kebriaei , Tapan M. Kadia , Gautam Borthakur , Naveen Pemmaraju , Rebecca Garris , Divyam Bansal , Sergej Konoplev , Sa A Wang , Wei Wang , Guilin Tang , Keyur P. Patel , Marina Konopleva , Nitin Jain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Acute Leukemia

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7040)

DOI

10.1200/JCO.2022.40.16_suppl.7040

Abstract #

7040

Poster Bd #

271

Abstract Disclosures